Vulnerability to tardive dyskinesia development in schizophrenia: An FDG-PET study of cerebral metabolism

Neuropsychopharmacology

Volumn 15, Issue 6, 1996, Pages 567-575

  Szymanski, Sally ^a,b   Gur, Ruben C ^a   Gallacher, Fiona ^a   Mozley, Lyn Harper ^a   Gur, Raquel E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Neuroimaging; Schizophrenia; Tardive dyskinesia

Indexed keywords

GLUCOSE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN METABOLISM; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIMBIC SYSTEM; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA; TARDIVE DYSKINESIA; TEMPORAL LOBE;

EID: 0030561082     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(96)00101-7     Document Type: Article

References (37)

1. Albus M, Naber D, Muller-Spahn F, Douillet P, Reinertshofer T, Achenheil M (1985): Tardive dyskinesia: Relation to computer-tomographic, endocrine, and psychopathological variables. Biol Psychiatry 20(10): 1082-1089
2. American Psychiatric Association DSM-III-R (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd edition revised. Washington, DC: American Psychiatric Press
3. 2 receptor binding. J Neural Trans Gen Section 79:215-216
4. Andreasen NC (1984a): The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA: The University of Iowa.
5. Andreasen NC (1984b): The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, IA: the University of Iowa.
6. 2 receptors in tardive dyskinesia: PET study. J Neurol Neurosurg Psychiatry 52:1248-1252.
7. Braun AR, Stoetter B, Randolph C, Hsiao JK, Vladar K, Gernert J, Carson RE, Herscovitch P, Chase T (1993): The functional neuroanatomy of Tourette's Syndrome: An FDG-PET study. I. Regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology 9:277-291
8. Brownell AL, Hantraye P, Wullner U, Hamberg L, Shoup T, Elmaleh DR, Firm DM, Madras BK, Brownell GL, Rosen BR (1994): PET-and MRI-based assessment of glucose utilization, dopamine receptor binding and hemodynamic changes after lesions to the caudate-putamen in primates. Exp Neurol 125:41-51
9. Casey DE (1993): Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. Psychopharmacology 16:589-610
10. Cohen H, Cohen D (1993): What may be gained from neuropsychological investigations of tardive dyskinesia? Brain Cogn 23:1-7
11. Cowell PE, Turetsky BT, Gur RC, Grossman RI, Shtasel DL, Gur RE (1994): Sex differences in aging of the human frontal and temporal lobe. J Neurosci 14:4748-4755
12. Dalgalarrondo P, Gattaz WF (1994): Basal ganglia abnormalities in tardive dyskinesia. Possible relationship with duration of neuroleptic treatment. Eur Arch Psychaitry Clin Neurosci 244(5):272-277
13. Elkashef AM, Buchanan RW, Gellad F, Munson RC, Breier A (1994): Basal ganglia pathology in schizophrenia and tardive dyskinesia: An MRI quantitative study. Am J Psychiatry 151(5):752-755
14. Gold JM, Egan MF, Kirch DG, Goldberg TE, Daniel DG, Bigelow LB, Wyatt RJ (1991): Tardive dyskinesia: Neuropsychological, computerized tomographic, and psychiatric symptom findings. Biol Psychiatry 30(6):587-599
15. Gur RC, Mozley PD, Resnick SM, Karp JS, Alavi A, Arnold SE, Gur RE (1995): Sex differences in regional cerebral glucose metabolism during a resting state. Science 267:528-531
16. Gur RE, Mozley PD, Resnick SM, Shtasel D, Kohn M, Zimmerman R, Herman G, Atlas S, Grossman R, Erwin R, Gur RC (1991): Magnetic resonance imaging in schizophrenia I. Volumetric analysis of brain and cerebrospinal fluid. Arch Gen Psychiatry 48:407-412
17. Gur RE, Mozley PD, Shastel DL, Cannon TD, Gallacher D, Turetsky B, Grossman R, Gur RC (1994): Clinical subtypes of schizophrenia differ in brain and cerebrospinal fluid volume. Am J Psychiatry 151:343-350
18. Gur RE, Mozley PD, Resnick SM, Harper-Mozley L, Shastel DL, Gallacher F, Arnold SE, Karp JS, Alavi A, Reivich M, Gur RC, (1995): Resting cerebral glucose in first-episode and previously treated patients with schizophrenia relates to clinical features. Arch Gen Psychiatry 52:657-667
19. Heinz R, Rayasam K, Krishnan KR, Wingfield M, Irigaray P, Ellinwood EH (1988): MRI scans in patients with tardive dyskinesia. Biol Psychiatry 24(7):852-857
20. Hockberg Y, Benjamini Y (1990): More powerful procedures for multiple significance testing. Stat Med 9:811-818
21. Hoffman WF, Casey DE (1991): Computed tomographic evaluation of patients with tardive dyskinesia. Schizophr Res 5:1-12
22. Kareken DA, Gur RC, Mozley PD, Mozley LH, Saykin AJ, Shtasel DL, Gur RE (1995): Cognitive functioning and neuroanatomic volume measures in schizophrenia. Neuropsychology 9:211-219
23. Karp JS, Muehllehner G, Mankoff DA, Ordonez CE, Ollonger JM, Daube-Witherspoon ME, Haigh AT, Beerbohm DJ (1990): Continuous slice PENN-PET: A positron tomograph with volume imaging capability. J Nucl Med 5:517-527
24. Karp JS, Daube-Witherspoon ME, Muehllehner G (1991): Factors affecting accuracy and precision in PET volume imaging. J Cereb Blood Flow Metab 14:A38-A44
25. Kohn MI, Tanna NK, Herman GT, Resnick SM, Mozley PD, Gur RE, Alavi A, Zimmerman RA, Gur RC (1991): Analysis of brain and CSF volumes from magnetic resonance imaging: methodology, reliability and validation. Radiology 178:115-122
26. Mion CC, Andreasen NC, Arndt S, Swayze VW, Cohen C (1991): MRI abnormalities in tardive dyskinesia. Psychiatry Res 40(3):157-166
27. Overall JR, Gorham DR (1962): The brief psychiatric rating scale. Psychol Rep 10:799-812
28. Reivich M, Kuhl D, Wolf AP, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Som P, Sokoloff L (1979): The 18 F-fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 44:127-137
29. Reivich M, Alavi A, Wolf AP, Fowler JS, Russell J, Arnett C, MacGregor RR, Shive CY, Atkins H, Anand A, Dann R, Greenberg JH (1985): Glucose metabolic rate kinetic model parameter determination in man. The lumped constants and rate constants for 18F-Fluorodeoxyglucose and 11C-Deoxyglucose. J Cereb Blood Flow Metab 5:179-192
30. Resnick SM, Karp JS, Turetsky B, Gur RE (1993): Comparison of anatomically-defined versus physiologically-based regional localization: Effects on PET-FDG quantiifcation. J Nucl Med 34:2201-2207
31. Saykin AJ, Gur RC, Gur RE, Mozley D, Mozley LH, Resnick SM, Kester DB, Stafiniak P (1991): Neuropsychological function in schizophrenia: Selective impairment in memory and learning. Arch Gen Psychiatry 48:618-624
32. Saykin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH, Stafiniak P, Gur RC (1994): Neuropsychological deficits in neuroleptic naive, first episode schizophrenic patients. Arch Gen Psychiatry 51:124-131
33. Schooler N, Kane J (1982): Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 391:486-487
34. Simpson GM, Lee JH, Zoubek B, Gardos G (1979): A rating scale for tardive dyskinesia. Psychopharmacology 64: 171-179
35. Turetsky BT, Cowell PE, Gur RC, Grossman RI, Shtasel DL, Gur RE (1995): Frontal and temporal lobe brain volumes in schizophrenia: Relationship to symptomotology and clinical subtype. Arch Gen Psychiatry, in press.
36. Waddington JL, Youssef HA, Dolphin C, Kinsell A (1987): Cognitive dysfunction, negative symptoms and tardive dyskinesia in schizophrenia: Their association in relation to topography of involuntary movements and criterion of their abnormality. Arch Gen Psychiatry 44: 907-912
37. Waddington JL (1993): Cognitive dysfunction in schizophrenia: Organic vulnerability factor or state marker for tardive dyskinesia? Brain Cogn 23:56-70